Article
Examining the feasibility of clinical grade CD271+ enrichment of mesenchymal stromal cells for bone regeneration.
PloS one - 1 Jan 2015
Cuthbert Richard J, Giannoudis Peter V, Wang Xiao N, Nicholson Lindsay, Pawson David, Lubenko Anatole, Tan Hiang B, Dickinson Anne, McGonagle Dennis, Jones Elena
Abstract excerpt
INTRODUCTION: Current clinical trials utilize mesenchymal stromal cells (MSCs) expanded in culture, however these interventions carry considerable costs and concerns pertaining to culture-induced losses of potency. This study assessed the feasibility of new clinical-grade technology to obtain uncultured MSC isolates from three human intra-osseous tissue sources based on immunomagnetic selection for CD271-positive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
